Bright Minds Biosciences Inc.

DRUG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001827401

SEC filings (opens in a new tab)

No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Bright Minds Biosciences Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of DRUG: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	9	9	0
Shares	418.4K	583.6K	+165.2K (+39.5%)
Value	$309.6K	$256.7K	−$52.9K (−17.1%)

New holders (2)

Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to DRUG in Q1 2023
Institution	Shares	Value	% of portfolio
Sawtooth Solutions, LLC	46,204	$20.3K	0.00%
Renaissance Technologies LLC	27,704	$12.0K	0.00%

Sold out (2)

Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of DRUG in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Virtu Financial LLC	38,715	$29.0K
StoneX Group Inc.	10,193	$7.54K